192 related articles for article (PubMed ID: 19844670)
1. Prevalence and correlates of hepatitis C infection among male injection drug users in detention, Tehran, Iran.
Kheirandish P; SeyedAlinaghi S; Jahani M; Shirzad H; Seyed Ahmadian M; Majidi A; Sharifi A; Hosseini M; Mohraz M; McFarland W
J Urban Health; 2009 Nov; 86(6):902-8. PubMed ID: 19844670
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and correlates of co-infection with human immunodeficiency virus and hepatitis C virus in male injection drug users in Iran.
Hosseini M; SeyedAlinaghi S; Kheirandish P; Esmaeli Javid G; Shirzad H; Karami N; Jahani M; Seyed Ahmadian M; Payvarmehr F; Mohraz M; Emadi Koochak H; McFarland W
Arch Iran Med; 2010 Jul; 13(4):318-23. PubMed ID: 20597566
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran.
Zamani S; Ichikawa S; Nassirimanesh B; Vazirian M; Ichikawa K; Gouya MM; Afshar P; Ono-Kihara M; Ravari SM; Kihara M
Int J Drug Policy; 2007 Oct; 18(5):359-63. PubMed ID: 17854723
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and correlates of HIV infection among male injection drug users in detention in Tehran, Iran.
Kheirandish P; Seyedalinaghi SA; Hosseini M; Jahani MR; Shirzad H; Foroughi M; Ahmadian MR; Jabbari H; Mohraz M; McFarland W
J Acquir Immune Defic Syndr; 2010 Feb; 53(2):273-5. PubMed ID: 20104123
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilan province.
Mohtasham Amiri Z; Rezvani M; Jafari Shakib R; Jafari Shakib A
East Mediterr Health J; 2007; 13(2):250-6. PubMed ID: 17684845
[TBL] [Abstract][Full Text] [Related]
6. The seroprevalence of untreated chronic hepatitis C virus (HCV) infection and associated risk factors in male Irish prisoners: a cross-sectional study, 2017.
Crowley D; Lambert JS; Betts-Symonds G; Cullen W; Keevans M; Kelly E; Laird E; McHugh T; McKiernan S; Miggin SJ; Murphy C; Murtagh R; O'Reilly D; Tobin C; Van Hout MC
Euro Surveill; 2019 Apr; 24(14):. PubMed ID: 30968825
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Hepatitis B and C among Drug-Abusing Male Prisoners in Birjand, South Khorasan, Iran.
Ghafari S; Sharifzadeh G; Jamali S; Taji B; Javadmoosavi SY; Ziaee M
Arch Iran Med; 2019 Sep; 22(9):501-504. PubMed ID: 31679371
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence study of HCV among hospitalized intravenous drug users in Ahvaz, Iran (2001-2006).
Alavi SM; Alavi L
J Infect Public Health; 2009; 2(1):47-51. PubMed ID: 20701860
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of and risk factors for HCV among incarcerated people at Great Tehran Prison: a cross-sectional study.
SeyedAlinaghi S; Farhoudi B; Shahmohamadi E; Rasoolinejad M; Hasannezhad M; Rashidi MR; Dadras O; Moradi A; Parmoon Z; Ebrahimi H; Asadollahi-Amin A
Int J Prison Health; 2023 Feb; ():. PubMed ID: 36757302
[TBL] [Abstract][Full Text] [Related]
10. Intravenous drugs abuse as the main risk factor of increasing hepatitis C infection prevalence in prisoners in Zenica, Bosnia and Herzegovina.
Hodžić H; Bajramović A; Obradović Z; Mahmić-Kaknjo M
Med Glas (Zenica); 2017 Feb; 14(1):73-78. PubMed ID: 28165441
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of hepatitis C and correlates of seropositivity among men who have sex with men in Vancouver, Canada: a cross-sectional survey.
Wong J; Moore D; Kanters S; Buxton J; Robert W; Gustafson R; Hogg R; Ogunnaike-Cooke S; Wong T; Gilbert M;
Sex Transm Infect; 2015 Sep; 91(6):430-3. PubMed ID: 25872512
[TBL] [Abstract][Full Text] [Related]
12. Correlates of Hepatitis C Virus Infection in the Targeted Testing Program of the New York City Jail System.
Akiyama MJ; Kaba F; Rosner Z; Alper H; Kopolow A; Litwin AH; Venters H; MacDonald R
Public Health Rep; 2017; 132(1):41-47. PubMed ID: 28005477
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.
Santana Rodríguez OE; Malé Gil ML; HernándezSantana JF; Limiñana Cañal JM; Martín Sánchez AM
Eur J Epidemiol; 1998 Sep; 14(6):555-61. PubMed ID: 9794122
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence and Related Risk Behaviors of Hepatitis C, Hepatitis B and HIV Infections among Male Prisoners in Kermanshah, Iran.
Khademi N; Skakiba E; Khodadoust M; Khoramdad M
Arch Iran Med; 2019 Oct; 22(10):588-591. PubMed ID: 31679361
[TBL] [Abstract][Full Text] [Related]
15. Predictors of Drug Injection in High-Risk Populations of Prisoners with a History of Tattooing: A Cross-Sectional Study.
Jafari S; Moradi G; Gouya MM; Azimian Zavareh F; Ghaderi E
J Res Health Sci; 2019 Jan; 19(1):e00435. PubMed ID: 31133625
[TBL] [Abstract][Full Text] [Related]
16. Blood-borne hepatitis in opiate users in iran: a poor outlook and urgent need to change nationwide screening policy.
Honarvar B; Odoomi N; Moghadami M; Afsar Kazerooni P; Hassanabadi A; Zare Dolatabadi P; Farzanfar E; Lankarani KB
PLoS One; 2013; 8(12):e82230. PubMed ID: 24312645
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of and risk factors for HBV and HCV among incarcerated people who inject drugs in Iran: A cross sectional study.
Moradi G; Mohamadi P; Zareie B; Rasouli MA; Gouya MM; Jafari S
BMC Infect Dis; 2020 Oct; 20(1):806. PubMed ID: 33129259
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C among vulnerable populations: A seroprevalence study of homeless, people who inject drugs and prisoners in London.
Aisyah DN; Shallcross L; Hayward A; Aldridge RW; Hemming S; Yates S; Ferenando G; Possas L; Garber E; Watson JM; Geretti AM; McHugh TD; Lipman M; Story A
J Viral Hepat; 2018 Nov; 25(11):1260-1269. PubMed ID: 29851232
[TBL] [Abstract][Full Text] [Related]
19. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
Rahimi-Movaghar A; Razaghi EM; Sahimi-Izadian E; Amin-Esmaeili M
Int J Infect Dis; 2010 Jan; 14(1):e28-33. PubMed ID: 19464218
[TBL] [Abstract][Full Text] [Related]
20. High hepatitis C virus prevalence among drug users in Iran: systematic review and meta-analysis of epidemiological evidence (2001-2012).
Malekinejad M; Navadeh S; Lotfizadeh A; Rahimi-Movaghar A; Amin-Esmaeili M; Noroozi A
Int J Infect Dis; 2015 Nov; 40():116-30. PubMed ID: 26460088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
